In September, the German health authorities extended the manufacturer’s authorisation for LTS Lohmann Therapie-Systeme AG (LTS) to include capsules.

Upon the successful inspection, the competent national authority granted LTS the extension of its current manufacturer’s authorisation according to §13 AMG to include the manufacturing of capsules. LTS passed a significant milestone towards the marketing of a new innovative drug delivery system allowing, for example, the combination of oral thin films with capsules.